Inventor

GROSS MITCHELL STUART

US12 patents

⚠️ This page may combine multiple inventors who share the name “GROSS MITCHELL STUART”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITHKLINE BEECHAM CORP

9 patents

US6129913AOct 10, 2000

Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

SMITHKLINE BEECHAM CORP68 citations95

US5928904AJul 27, 1999

DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders

SMITHKLINE BEECHAM CORP59 citations94

US5683892ANov 4, 1997

DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

SMITHKLINE BEECHAM CORP35 citations94

US6005091ADec 21, 1999

Nucleic acids encoding immunoglobulin domains

SMITHKLINE BEECHAM CORP57 citations91

US5851525ADec 22, 1998

Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

SMITHKLINE BEECHAM CORP29 citations91

US5693323ADec 2, 1997

Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

SMITHKLINE BEECHAM CORP30 citations91

US5914110AJun 22, 1999

Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders

SMITHKLINE BEECHAM CORP31 citations90

US6391299B1May 21, 2002

Anti-factor IX/IXa antibodies

SMITHKLINE BEECHAM CORP33 citations88

US7399837B2Jul 15, 2008

Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

SMITHKLINE BEECHAM CORP13 citations83

GLAXOSMITHKLINE LLC

2 patents

US7982005B2Jul 19, 2011

Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

GLAXOSMITHKLINE LLC44 citations96

US7807793B2Oct 5, 2010

Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders

GLAXOSMITHKLINE LLC0 citations39

SMITHKLINE BEECHAM PLC

1 patent

US6946130B2Sep 20, 2005

Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

SMITHKLINE BEECHAM PLC13 citations91